Apolipoprotein E polymorphism in non-insulin-dependent diabetics of Mumbai, India and its effect on plasma lipids and lipoproteins

Diabetes Research and Clinical Practice

Volumn 47, Issue 3, 2000, Pages 217-223

  Inamdar, P A ^a   Kelkar, S M ^b   Devasagayam, T P A ^b   Bapat, M M ^a  

^a INSTITUTE OF SCIENCE   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

ApoE polymorphism; Hypercholesterolemia; Hypertriglyceridemia; Lipoproteins; NIDDM

Indexed keywords

APOLIPOPROTEIN E; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INDIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE;

ADULT; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIA; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0033956223     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00126-6     Document Type: Article

References (23)

1. Mahley R.W. ApolipoproteinE: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
2. Utermann G., Hees M., Steinmetz A. Polymorphism of apoE and occurrence of dysbetalipoproteinemia in man. Nature. 269:1977;604-607.
3. Zannis G.I., Breslow J.L. Human very low density lipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry. 20:1981;1033-1041.
4. Smitt M., deKnijff P., Rosseneu M., Bury J., Klasen E., Frants R. et al. ApolipoproteinE polymorphism in Netherlands and its effects on plasma lipid and apolipoprotein levels. Hum. Genet. 80:1988;287-292.
5. Sing C.F., Davignon J. Role of apolipoproteinE polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37:1985;268-285.
6. Semenkovich C.F., Heinecke J.W. The mystery of diabetes and atherosclerosis - Time for a new plot. Diabetes. 46:1997;327-334.
7. Hallmann D.M., Boerwinkle E., Saha N., Sandholzer C., Menzel H.J., Csazar A. et al. The apolipoproteinE polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:1991;338-349.
8. Gerdes L.U., Klausnen C.I., Sihm I., Faergeman O. ApolipoproteinE polymorphism in a Danish population compared to findings in 45 other populations around the world. Genet. Epidemiol. 9:1992;155-167.
9. Boer J.M.A., Ehnholm C., Menzel H.J., Havekes L.M., Rosseneu M., O'Reilly D.S. et al. Interactions between lifestyle-related factors and the apoE polymorphism on plasma lipids and apolipoproteins. The EARS study. Arterioscler. Thromb. Vasc. Biol. 17:1997;1675-1681.
10. Hong S.H., Kang B.Y., Oh J.H., Kim J.Q., Lee C.C. Genetic variations of the apoE-CI-CII cluster gene in Koreans. Clin. Biochem. 30:1997;215-219.
11. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28 (1979) 1039-57.
12. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30:1983;111-118.
13. Warnick G.R., Mayfield C., Albers J.J., Hazzard W.R. Gel isoelectricfocusing method for specific diagnosis of familial hyperlipoproteinemia type3. Clin. Chem. 25:1979;279-284.
14. Eto M., Watanabe K., Ishii K. A rapid flat gel isoelectricfocusing method for determination of apolipoproteinE phenotypes and its application. Clin. Chem. 149:1985;121-128.
15. Davignon G., Gregg R.E., Sing C.F. ApolipoproteinE polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
16. Weisgraber K.H., Hall S.C., Mahley R.W. Human E apoprotein heterogenity: cysteine-arginine interchanges in the amino acid sequence of the apoE isoforms. J. Biol. Chem. 256:1981;9077-9083.
17. Gueguen R., Visvikis S., Steinmetz J., Siest G., Boerwinkle E. An analysis of genotype effects and their interactions by using the apolipoproteinE polymorphism and longitudnal data. Am. J. Hum. Genet. 45:1989;793-802.
18. Eto M., Watanabe K., Makino I. Increased frequencies of apolipoproteinE2 and E4 alleles in the patients with ischemic heart disease. Clin. Genet. 36:1989;183-188.
19. M. Eto, Y. Watanabe, A. Iwashima, E. Morikawa, M. Oshima, Sekiguchi, et al., Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes 35 (1986) 1374-82.
20. Utremann G. ApolipoproteinE polymorphism in health and disease. Am. Heart J. 113:1987;433-438.
21. Ghiselli R., Gregg R.E., Zech L.A., Schaefer E.J., Brewer H.B. Jr. Phenotype study of apolipoproteinE isoforms in hyperlipoproteinemic patients. Lancet. 2:1982;405-407.
22. Gregg R.E., Zech L.A., Schaefer E.J., Brewer H.B. Jr. ApolipoproteinE metabolism in normolipoproteinemic human subjects. J. Lipid Res. 25:1984;1167-1176.
23. Pasagian-MaCaulay A., Aston C.F., Ferrell R.E., McAllister A.E., Wing R.R., Kuller L.H. A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the apoE locus gene. Atherosclerosis. 132:1997;221-227.